Author Archives: cchrstl

The New York Times November 30, 2008 Editorial http://www.nytimes.com/2008/11/30/opinion/30sun2.html?_r=1 Expert or Shill? More evidence has emerged of appalling conflicts of interest that throw into doubt the advice rendered and the research performed by two prominent psychiatrists who have received substantial … Continue reading →

Psychiatry is facing unprecedented exposure for drugging children with unapproved psychotropic drugs, and for ties to drug companies.  In less than a week we’ve seen coverage in the Wall Street Journal, New York Times, USA Today, Boston Globe and LA … Continue reading →

By Rita Rubin, USA TODAY 11/24/2008 Among all the drugs prescribed to treat conditions for which they’re not approved, doctors and patients should be most concerned about antipsychotics and antidepressants, a study suggests today. This “off-label” prescribing is a legal, … Continue reading →

http://www.bloomberg.com/apps/news?pid=20601087&sid=atN6Se0NVbp0&refer=home By Rob Waters and Julie Ziegler Nov. 25 (Bloomberg) — Massachusetts General Hospital will investigate conflicts of interest at a child psychiatry research center it established with funding from Johnson & Johnson, maker of the antipsychotic drug Risperdal. The … Continue reading →

By GARDINER HARRIS November 25, 2008 The New York Times http://www.nytimes.com/2008/11/25/health/25psych.html?_r=1 When a Congressional investigation revealed in June that Dr. Joseph Biederman, a world-renowned child psychiatrist, had earned far more money from drug makers than he had reported to his … Continue reading →

This is an overview, in no particular order, of what is publicly known about Douglas Geenens. Douglas Lee Geenens, D.O., is a Kansas City area physician who specializes in psychiatry and child psychiatry. He has operated mainly in the Overland … Continue reading →

By Ed Silverman http://www.pharmalot.com/2008/11/psychotic-reaction-treating-adhd-in-maine/ November 20th, 2008 Earlier this week, the FDA advisory committee slammed the rising use of antipsychotics in youngsters, particularly to treat attention deficit disorders. The meds, you see, were approved by the agency for schiozphrenia or … Continue reading →

November 18th, 2008 http://www.aboutlawsuits.com/fda-panel-to-review-zyprexa-side-effects-for-children-1774/ At a meeting of the FDA’s Pediatric Advisory Committee today [11/18/08], potential label changes will be considered for Eli Lilly’s antipsychotic drug Zyprexa. The Committee will evaluate whether new warnings are necessary about the risk of … Continue reading →

From The New York Times November 18, 2008 By GARDINER HARRIS Powerful antipsychotic medicines are being used far too cavalierly in children, and federal drug regulators must do more to warn doctors of their substantial risks, a panel of federal … Continue reading →

from The New York Times November 22, 2008 By GARDINER HARRIS http://www.nytimes.com/2008/11/22/health/22radio.html?emc=eta1 An influential psychiatrist who was the host of the popular NPR program “The Infinite Mind” earned at least $1.3 million from 2000 to 2007 giving marketing lectures for … Continue reading →